CLINICAL_TRIALS
trial_result
· 2022-12-19
Clinical Trial Update: Cadonilimab in the Treatment of Advanced Soft Tissue Sarcoma [Phase 2]
Summary
Phase 2 clinical trial update for cadonilimab in advanced soft tissue sarcoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Peking University Cancer Hospital & Institute | Conditions: Soft Tissue Sarcoma | Phase 2 | Status: UNKNOWN